Progyny Balance Sheet
PGNY / Health Care|9 years of annual SEC 10-K data (FY2017-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 9 fiscal years. All figures from audited SEC 10-K filings.
Progyny had $742M in total assets and $516M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 3.62 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $112.2M | $162.3M | $97.3M | $120.1M | $91.4M | $70.3M | $80.4M | $127.0K | - |
| Accounts Receivable | $220.3M | $235.3M | $241.9M | $240.1M | $134.6M | $75.7M | $47.1M | $23.3M | - |
| Current Assets | $551.8M | $472.7M | $640.4M | $433.9M | $258.5M | $190.2M | $132.4M | $24.5M | - |
| PP&E (Net) | $29.9M | $12.4M | $10.2M | $8.4M | $5.0M | $3.4M | $3.1M | $776.0K | - |
| Goodwill | $20.0M | $15.5M | $11.9M | $11.9M | $11.9M | $11.9M | $11.9M | $11.9M | - |
| Total Assets | $742.4M | $607.1M | $756.6M | $543.0M | $358.1M | $253.9M | $150.4M | $41.3M | - |
| Current Liabilities | $202.4M | $168.6M | $185.9M | $159.5M | $98.8M | $77.8M | $36.2M | $30.2M | - |
| Shareholders' Equity | $516.0M | $422.1M | $553.4M | $377.0M | $251.8M | $166.9M | $114.3M | -$95.1M | -$97.6M |